Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The composite endogenous growth factor network is a conceptual framework representing the complex, interconnected signaling pathways involving various growth factors such as VEGF, FGF, PDGF, and TGF-beta. These factors work in concert to regulate fundamental cellular processes including proliferation, differentiation, and survival. In a physiological context, this network is essential for tissue repair, embryonic development, and maintaining homeostasis. However, dysregulation of this network is a hallmark of many diseases, particularly cancer, where overactive signaling drives tumor growth and metastasis. Because it describes a broad biological system rather than a single molecular entity, it is not considered a discrete therapeutic target, although individual components within the network are frequently targeted by specific inhibitors or monoclonal antibodies.
Not applicable as this is a conceptual network of multiple signaling molecules rather than a single drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Composite endogenous growth factor network (CEGFN).